Immune cells in lung cancer and chronic lung disease
Part of Blood & lymphatic, Cancer, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how immune cells work in lung cancer and chronic lung diseases. It aims to find better ways to treat these conditions by studying immune cells from blood, bone marrow, or lung samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lung cancer, a precancerous lung spot, or a chronic lung condition like sarcoidosis or COPD.
- You are not taking more than 10 mg of prednisone (or similar steroid) daily.
- You do not have an active infection at the time of joining the study.
- You are able to give consent (or have a parent/guardian do so).
- If you have a chronic lung condition, you are not currently on immunosuppressive therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body’s “innate” (first-line) immune system works in people with COPD compared with healthy volunteers. It may help researchers understand COPD inflammation and how immune responses could be targeted in the future.
This study is looking at biomarkers (clues in your blood and tumor) to better understand how advanced lung cancer responds to immunotherapy. It aims to help doctors predict which treatments might work best for you in the future.
This study examines how certain white blood cells behave in people with lung cancer or COPD. It aims to better understand the immune response, which could help develop new treatments.
This study collects blood and sputum (phlegm) samples from people with lung cancer before and during immunotherapy. The goal is to see if certain immune markers in these samples can predict how well the treatment works.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study looks for biological markers (special signs in your body) that could help doctors choose better immune-based treatments for non-small cell lung cancer. Researchers will study your tumor and blood to understand which patients might benefit most from immunotherapy.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.